Tumour response of osteosarcoma to neoadjuvant chemotherapy evaluated by magnetic resonance imaging as prognostic factor for outcome

被引：0
|
作者：
Christoph J. Laux
Gundula Berzaczy
Michael Weber
Susanna Lang
Martin Dominkus
Reinhard Windhager
Iris-Melanie Nöbauer-Huhmann
Philipp T. Funovics
机构：
[1] Medical University of Vienna,Department of Orthopaedic Surgery
[2] Medical University of Vienna,Department of Radiology
[3] Medical University of Vienna,Department of Clinical Pathology
来源：
International Orthopaedics | 2015年 / 39卷
关键词：
Osteosarcoma; Prognosis; Neoadjuvant chemotherapy; MRI volumetry; Histological response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：97 / 104
页数：7
相关论文
共 50 条
  • [31] ASSESSING THE BEST MEASURE OF TUMOR SIZE AS A PROGNOSTIC FACTOR IN OSTEOSARCOMA AFTER NEOADJUVANT CHEMOTHERAPY
    REHAN, N
    BIELING, P
    WINKLER, P
    HELMKE, K
    MAAS, R
    BALDINI, N
    HEISE, U
    FUCHS, N
    WINKLER, K
    KLINISCHE PADIATRIE, 1993, 205 (04): : 200 - 209
  • [32] MAGNETIC-RESONANCE IMAGING (MRI) IN EVALUATING INVIVO RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR OSTEOSARCOMAS OF THE EXTREMITIES
    HOGEBOOM, WR
    HOEKSTRA, HJ
    MOOYAART, EL
    OOSTERHUIS, JW
    POSTMA, A
    VETH, RPH
    KOOPS, HS
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1989, 15 (05): : 424 - 430
  • [33] OSTEOSARCOMA - CHEMOTHERAPY EFFECT - A PROGNOSTIC FACTOR
    RAYMOND, AK
    AYALA, A
    BENJAMIN, R
    CHAWLA, S
    CARRASCO, C
    WALLACE, S
    MURRAY, J
    LABORATORY INVESTIGATION, 1987, 56 (01) : A63 - A63
  • [34] Relevance of breast cancer subtypes for magnetic resonance imaging response monitoring during neoadjuvant chemotherapy
    Cesar Gómez-Raposo
    Mónica Andreu
    Inés Suárez-García
    M. Isabel Esteban
    Mar Carballo
    María F. Sereno-Moyano
    José L. Vázquez Osorio
    Javier Heras
    Francisco Zambrana Tévar
    Eva Pelayo
    Miriam López-Gómez
    Clara García de Santiago
    María Merino Salvador
    Enrique Casado
    Clinical and Translational Oncology, 2012, 14 : 486 - 488
  • [35] Prediction of pathological complete response to neoadjuvant chemotherapy by magnetic resonance imaging in breast cancer patients
    Michishita, Shintaro
    Kim, Seung Jin
    Shimazu, Kenzo
    Sota, Yoshiaki
    Naoi, Yasuto
    Maruyama, Naomi
    Kagara, Naofumi
    Shimoda, Masafumi
    Shimomura, Atsushi
    Noguchi, Shinzaburo
    BREAST, 2015, 24 (02): : 159 - 165
  • [36] Relevance of breast cancer subtypes for magnetic resonance imaging response monitoring during neoadjuvant chemotherapy
    Gomez-Raposo, Cesar
    Andreu, Monica
    Suarez-Garcia, Ines
    Isabel Esteban, M.
    Carballo, Mar
    Sereno-Moyano, Maria F.
    Vazquez Osorio, Jose L.
    Heras, Javier
    Zambrana Tevar, Francisco
    Pelayo, Eva
    Lopez-Gomez, Miriam
    Garcia de Santiago, Clara
    Merino Salvador, Maria
    Casado, Enrique
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (06): : 486 - 488
  • [37] Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk
    Mark Jesus M. Magbanua
    Wen Li
    Denise M. Wolf
    Christina Yau
    Gillian L. Hirst
    Lamorna Brown Swigart
    David C. Newitt
    Jessica Gibbs
    Amy L. Delson
    Ekaterina Kalashnikova
    Alexey Aleshin
    Bernhard Zimmermann
    A. Jo Chien
    Debu Tripathy
    Laura Esserman
    Nola Hylton
    Laura van ‘t Veer
    npj Breast Cancer, 7
  • [38] Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk
    Magbanua, Mark Jesus M.
    Li, Wen
    Wolf, Denise M.
    Yau, Christina
    Hirst, Gillian L.
    Swigart, Lamorna Brown
    Newitt, David C.
    Gibbs, Jessica
    Delson, Amy L.
    Kalashnikova, Ekaterina
    Aleshin, Alexey
    Zimmermann, Bernhard
    Chien, A. Jo
    Tripathy, Debu
    Esserman, Laura
    Hylton, Nola
    van't Veer, Laura
    NPJ BREAST CANCER, 2021, 7 (01)
  • [39] Accuracy of Breast Magnetic Resonance Imaging in Predicting Pathologic Response in Patients Treated With Neoadjuvant Chemotherapy
    De Los Santos, Jennifer
    Bernreuter, Wanda
    Keene, Kimberly
    Krontiras, Helen
    Carpenter, John
    Bland, Kirby
    Cantor, Alan
    Forero, Andres
    CLINICAL BREAST CANCER, 2011, 11 (05) : 312 - 319
  • [40] Machine learning with multiparametric magnetic resonance imaging of the breast for early prediction of response to neoadjuvant chemotherapy
    Lo Gullo, Roberto
    Eskreis-Winkler, Sarah
    Morris, Elizabeth A.
    Pinker, Katja
    BREAST, 2020, 49 : 115 - 122
12345